GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Gross Margin %

Microba Life Sciences (ASX:MAP) Gross Margin % : 42.84% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Microba Life Sciences's Gross Profit for the six months ended in Dec. 2023 was A$1.40 Mil. Microba Life Sciences's Revenue for the six months ended in Dec. 2023 was A$3.27 Mil. Therefore, Microba Life Sciences's Gross Margin % for the quarter that ended in Dec. 2023 was 42.84%.


The historical rank and industry rank for Microba Life Sciences's Gross Margin % or its related term are showing as below:

ASX:MAP' s Gross Margin % Range Over the Past 10 Years
Min: 29.49   Med: 49.94   Max: 50.46
Current: 29.49


During the past 2 years, the highest Gross Margin % of Microba Life Sciences was 50.46%. The lowest was 29.49%. And the median was 49.94%.

ASX:MAP's Gross Margin % is ranked worse than
75.36% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: 45.55 vs ASX:MAP: 29.49

Microba Life Sciences had a gross margin of 42.84% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Microba Life Sciences was 0.00% per year.


Microba Life Sciences Gross Margin % Historical Data

The historical data trend for Microba Life Sciences's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Gross Margin % Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Gross Margin %
50.46 49.41

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % - - - 16.12 42.84

Competitive Comparison of Microba Life Sciences's Gross Margin %

For the Diagnostics & Research subindustry, Microba Life Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microba Life Sciences's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's Gross Margin % falls into.



Microba Life Sciences Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Microba Life Sciences's Gross Margin for the fiscal year that ended in Jun. 2023 is calculated as

Gross Margin % (A: Jun. 2023 )=Gross Profit (A: Jun. 2023 ) / Revenue (A: Jun. 2023 )
=2.7 / 5.42
=(Revenue - Cost of Goods Sold) / Revenue
=(5.42 - 2.742) / 5.42
=49.41 %

Microba Life Sciences's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=1.4 / 3.273
=(Revenue - Cost of Goods Sold) / Revenue
=(3.273 - 1.871) / 3.273
=42.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Microba Life Sciences  (ASX:MAP) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Microba Life Sciences had a gross margin of 42.84% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Microba Life Sciences Gross Margin % Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Microba Life Sciences (ASX:MAP) Business Description

Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines